MedPath

HIMALAYA WELLNESS COMPANY

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

164

Active:3
Completed:68

Trial Phases

5 Phases

Phase 1:38
Phase 2:13
Phase 3:10
+2 more phases

Drug Approvals

4

NPRA:4

Drug Approvals

ABANA TABLETS

Approval Date
Jul 4, 2025
Company
himalaya wellness malaysia sdn. bhd.
NPRA

KOFLET SYRUP

Approval Date
Jul 4, 2025
Company
himalaya wellness malaysia sdn. bhd.
NPRA

DIAKOF LINCTUS

Approval Date
Jul 4, 2025
Company
himalaya wellness malaysia sdn. bhd.
NPRA

SEPTILIN TABLETS

Approval Date
Jul 4, 2025
Company
himalaya wellness malaysia sdn. bhd.
NPRA

Clinical Trials

Distribution across different clinical trial phases (145 trials with phase data)• Click on a phase to view related trials

Not Applicable
44 (30.3%)
Phase 1
38 (26.2%)
Phase 4
29 (20.0%)
Phase 2
13 (9.0%)
Phase 3
10 (6.9%)
phase_1_2
6 (4.1%)
phase_2_3
5 (3.4%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.